Ozanimod Interactions
There are 923 drugs known to interact with ozanimod, along with 10 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 479 are major, 412 are moderate, and 32 are minor.
- View all 923 medications that may interact with ozanimod
- View ozanimod alcohol/food interactions (2)
- View ozanimod disease interactions (10)
Most frequently checked interactions
View interaction reports for ozanimod and the medicines listed below.
- Afinitor Disperz (everolimus)
- Alimta (pemetrexed)
- CertaVite with Antioxidants (multivitamin with minerals)
- Cleocin (clindamycin)
- Combivir (lamivudine / zidovudine)
- Cotellic (cobimetinib)
- Delstrigo (doravirine / lamivudine / tenofovir disoproxil)
- Dexedrine (dextroamphetamine)
- Doxil (doxorubicin liposomal)
- Esbriet (pirfenidone)
- Firvanq (vancomycin)
- Gamimune N 5% (immune globulin intravenous)
- Gammaplex (immune globulin intravenous)
- Hemlibra (emicizumab)
- Intelence (etravirine)
- iPlex (mecasermin rinfabate)
- Kalydeco (ivacaftor)
- Keflex (cephalexin)
- Lipitor (atorvastatin)
- Mutamycin (mitomycin)
- Nizoral (ketoconazole)
- Nuedexta (dextromethorphan / quinidine)
- Oncovin (vincristine)
- Otezla (apremilast)
- Platinol (cisplatin)
- Prograf (tacrolimus)
- Protonix (pantoprazole)
- Recombinate (antihemophilic factor)
- Rixubis (coagulation factor ix)
- Sandostatin (octreotide)
Ozanimod alcohol/food interactions
There are 2 alcohol/food interactions with ozanimod.
Ozanimod disease interactions
There are 10 disease interactions with ozanimod which include:
- CV disease
- CV risks
- hypertension
- infections
- liver dysfunction
- respiratory toxicity
- vaccinations
- encephalopathy
- macular edema
- MS
Report options
More about ozanimod
- ozanimod consumer information
- Compare alternatives
- Reviews (8)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Kesimpta
Kesimpta is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Omvoh
Omvoh is used to treat moderate to severe ulcerative colitis or Crohn's disease in adults. This ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Rinvoq
Rinvoq (upadacitinib) is used to treat rheumatoid arthritis, psoriatic arthritis, atopic ...
Tremfya
Tremfya (guselkumab) injection is used to treat plaque psoriasis, psoriatic arthritis, ulcerative ...
Remicade
Remicade is used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn's ...
Mesalamine
Mesalamine is used to treat mild to moderate ulcerative colitis and prevent the symptoms of ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
